We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
-17.28%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$222M
AUM Growth
-$86.4M
Cap. Flow
-$22.6M
Cap. Flow %
-10.18%
Top 10 Hldgs %
33.77%
Holding
109
New
40
Increased
8
Reduced
21
Closed
35

Top Buys

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$11.9M
2
AMGN icon
Amgen
AMGN
+$7.88M
3
GILD icon
Gilead Sciences
GILD
+$7.77M
4
CELG
Celgene Corp
CELG
+$7.45M
5
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
+$6.84M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$12.1M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$10M
3
ENDP
Endo International plc
ENDP
+$9.56M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$9.04M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.41M

Sector Composition

Rank Sector Weight
1 Healthcare 82.57%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDUS
101
DELISTED
Radius Health, Inc.
RDUS
– –
-25,000
Closed -$1.69M
EVFM
102
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
– –
-478
Closed -$387K
KIN
103
DELISTED
Kindred Biosciences, Inc.
KIN
– –
-93,500
Closed -$638K
ALXN
104
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-50,000
Closed -$9.04M
WMGI
105
DELISTED
Wright Medical Group Inc
WMGI
– –
-150,000
Closed -$3.94M
AET
106
DELISTED
Aetna Inc
AET
– –
-40,000
Closed -$5.1M
GI
107
DELISTED
EndoChoice Holdings, Inc.
GI
– –
-300,000
Closed -$4.91M
CPHD
108
DELISTED
Cepheid Inc
CPHD
– –
-100,000
Closed -$6.12M
ANAC
109
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
– –
-65,000
Closed -$5.03M
1 2 3 4
5

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Ghost Tree Capital held 109 positions worth $222M, down 28% from $309M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ghost Tree Capital withdrew a net $22.6M in Q3 2015, closing 35 positions and reducing 21 holdings. Its most notable exit was Biogen, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 86% a quarter earlier, followed by Financials.

Against the trend, Ghost Tree Capital opened a new position in MALLINCKRODT PUBLIC LIMITED COMPANY worth $7.67M.

  • Ghost Tree Capital's largest Q3 2015 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 120,000 shares worth $7.67M.
  • Ghost Tree Capital added most to ZELTIQ Aesthetics, Inc. in Q3 2015, an estimated $2.81M increase.
  • Ghost Tree Capital's biggest Q3 2015 reduction was Portola Pharmaceuticals, Inc., cutting an estimated $7M.
  • Ghost Tree Capital fully exited Biogen in Q3 2015, selling an estimated $12.1M.
  • Ghost Tree Capital's ten largest holdings make up 34% of its $222M portfolio in Q3 2015.
  • Ghost Tree Capital opened 40 new positions and closed 35 in Q3 2015.
  • Ghost Tree Capital's portfolio value fell 28% quarter-over-quarter to $222M.

Based on Ghost Tree Capital's 13F filing for Q3 2015, filed 16 Nov 2015.